Skip to main content

2 Result(s)

within S J Dovedi Remove this filter Intensive / Critical Care Medicine Remove this filter

and

  1. Article

    Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

    Correction to: Leukemia (2017) 31, 1611–1621; doi:10.1038/leu.2016.352; published online 3 January 2017 Following the publication of this article, it was noted that the HTML version contained the wrong AAP dat...

    E J Cheadle, G Lipowska-Bhalla, S J Dovedi, E Fagnano, C Klein, J Honeychurch… in Leukemia (2017)

    Download PDF (35 KB) View Article

  2. Article

    Open Access

    A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

    Anti-CD20 monoclonal antibodies (mAb) such as rituximab have been proven to be highly effective at improving outcome in B-cell malignancies. However, many patients ultimately relapse and become refractory to t...

    E J Cheadle, G Lipowska-Bhalla, S J Dovedi, E Fagnano, C Klein, J Honeychurch… in Leukemia (2017)

    Download PDF (1382 KB) View Article